Hendrik Marinus Willem Verheul

Title: Hendrik Marinus Willem Verheul: Innovator in Antibody Research

Introduction

Hendrik Marinus Willem Verheul is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of single domain antibodies. With a total of 5 patents to his name, Verheul's work has the potential to impact various therapeutic applications.

Latest Patents

One of Verheul's latest patents focuses on single domain antibodies targeting CD1d. This invention relates to compounds, specifically polypeptides, that bind to the non-classical MHC protein CD1d and modulate its biological functions. The patent details compounds and polypeptides that consist of at least one single domain antibody, which specifically binds to CD1d. Additionally, the patent provides methods and uses for employing these compounds, polypeptides, and single-domain antibodies.

Career Highlights

Throughout his career, Verheul has worked with prominent companies in the biotechnology sector, including Lava Therapeutics N.V. and Lava Therapeutics B.V. His expertise in antibody research has positioned him as a key figure in the development of innovative therapeutic solutions.

Collaborations

Verheul has collaborated with several professionals in his field, including Renée Cornelia Gerarda De Bruin and Tanja Denise De Gruijl. These collaborations have further enhanced his research and development efforts.

Conclusion

Hendrik Marinus Willem Verheul is a distinguished inventor whose work in single domain antibodies has the potential to revolutionize therapeutic approaches. His contributions to biotechnology continue to pave the way for future innovations in the field.